Skip to content

Acupuncture with Dialectical Needle Insertion Combined with Acupoint Patching for the Prevention and Treatment of Bronchial Asthma

Dialectical Acupuncture with Implantation Combined with Acupoint Patch Application for the Prevention and Treatment of Bronchial Asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000936
Enrollment
Unknown
Registered
2026-04-12
Start date
2024-04-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma

Interventions

Leukotriene antagonist treatment group:Treat with leukotriene antagonists
Acupoint application therapy group:Adopt acupoint application therapy
Acupoint application combined with dialectical needle embedding treatment group:Adopt acupoint application combined with dialectical acupuncture needle embedding therapy

Sponsors

Shanghai xuhui district xujiahui community health service center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: a. Aged between 18 and 80 years old; b. Diagnosed with asthma; c. Have not received any asthma-related treatment within the past 3 months; d. Volunteer to participate in this trial and sign the informed consent form; e. Those who can answer questions clearly and cooperate independently to complete the scale.

Exclusion criteria

Exclusion criteria: a. Cough and asthma caused by coronary heart disease, tumors, etc.; b. Patients with comorbidities such as cardiovascular disease, liver and kidney dysfunction, autoimmune diseases, or mental illnesses; c. Patients who are intolerant to or unsuitable for acupuncture treatment;

Design outcomes

Primary

MeasureTime frame
Asthma Control Test;Asthma Quality of Life Questionnaire;

Countries

China

Contacts

Public ContactJiaqiong Xu

Shanghai xuhui district xujiahui community health service center

363462871@qq.com13817003020

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026